InsidersTradesSigma
Discover the full record of transactions filed by Watanabe Todd, See Remarks. Officer active across 1 companies, notably Arcutis Biotherapeutics, Inc.. Aggregated, 2 reports have been logged. Total volume traded: €1.7m. The latest transaction was disclosed on 28 October 2025 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Todd Watanabe is involved in various functions at Arcutis Biotherapeutics, Inc. His role includes specific responsibilities that contribute to the company's development and strategy. His expertise is an asset to the organization.